Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief

References

• Malanga GA, Ruoff GE, Weil AJ, et al. Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design. Curr Med Res Opin 2009;25:1179–96
   PubMed Web of Science ®Google Scholar
• James R, Weintraub DO. Treatment of acute migraine attacks. J Am Osteopath Assoc 2000;100:S1–7
   Google Scholar
• Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 2003;6:252–73
   PubMed Web of Science ®Google Scholar
• Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998;15:1326–31
   PubMed Web of Science ®Google Scholar
• Borchard G, Lueβen HL, de Boer AG, et al. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption: III. Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro. J Contro Release 1996;39:131–8
   Web of Science ®Google Scholar
• Lee K, Ha WS, Park WH. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 1995;16:1211–16
   PubMed Web of Science ®Google Scholar
• Snyder GH, Reddy MK, Cennerazzo MJ, Field D. Use of local electrostatic environments of cysteines to enhance formation of a desired species in a reversible disulfide exchange reaction. Biochim Biophys Acta 1983;749:219–26
   PubMed Web of Science ®Google Scholar
• Kotze AF, Luehen HL, de Leeuw BJ, et al. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur J Pharm Sci 1999;7:145–51
   PubMed Web of Science ®Google Scholar
• Sreenivas SA, Pai KV. Thiolated chitosans: novel polymers for mucoadhesive drug delivery – a review. Trop J Pharm Res 2008;7:1077–88
   Web of Science ®Google Scholar
• Andreas BS, Hornof M, Zoidl T. Thiolated polymers–thiomers: modification of chitosan with 2-iminothiolane. Int J Pharm 2003;260:229–37
   PubMed Web of Science ®Google Scholar
• Hornof MD, Kast CE, Andreas BS. In vitro evaluation of the viscoelastic behavior of chitosan–thioglycolic acid conjugates. Eur J Pharm Biopharm 2003;55:185–90
   PubMed Web of Science ®Google Scholar
• Soane RJ, Hinchcliffe M, Davis SS, Illum L. Clearance characteristics of chitosan based formulation in the sheep nasal cavity. Int J Pharm 2001;217:183–91
   PubMed Web of Science ®Google Scholar
• Desai M, Labhasetwar V, Amidon G, Levy R. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996;13:1838–45
   PubMed Web of Science ®Google Scholar
• Roghieh SS, Leigh C, Ogden C. Nanotechnology application for drug delivery. Pharm Technol Eur 2005;17:21–8
   Google Scholar
• Roldo M, Hornof M, Caliceti P, Bernkop-Schnürch A. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm 2004;57:115–21
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Weithaler A, Albrecht K, Greimel A. Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int J Pharm 2006;317:76–81
   PubMed Web of Science ®Google Scholar
• Xiaomei W, Chi N, Xing T. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 2008;70:735–40
   PubMed Web of Science ®Google Scholar
• Goycoolea FM, Lollo G, Remuñán-López C, et al. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules 2009;10:1736–43
   PubMed Web of Science ®Google Scholar
• Carmen P, Hayat O. Biodegradable nanoparticles incorporating highly hydrophilic positively charged drugs. United State Patent 2009;424489
   Google Scholar
• Yan W, Wuli Y, Changchun W, et al. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005;295:235–45
   PubMedGoogle Scholar
• Bai S, Yang T, Abbruscato TJ, Ahsan F. Evaluation of human nasal RPMI 2650 cells grown at an air–liquid interface as a model for nasal drug transport studies. J Pharm Sci 2008;97:1165–78
   PubMed Web of Science ®Google Scholar
• Maryam A, Stefan GR, Gerrit B, et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 2006;111:107–16
   PubMed Web of Science ®Google Scholar
• Shah P, Jogani V, Mishra P, et al. In vitro assessment of acyclovir permeation across cell monolayer in the presence of absorption enhancers. Drug Dev Ind Pharm 2008;34:279–88
   PubMed Web of Science ®Google Scholar
• Guggi D, Langoth N, Hoffer MH, et al. Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate. Int J Pharm 2004;278:353–60
   PubMed Web of Science ®Google Scholar
• Vyas TK, Babbar RK, Sharma S, Misra AN. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. J Pharm Sci 2006;95:1–11
   Web of Science ®Google Scholar
• Ghelardini C, Galeotti N, Grazioli I, Uslenghi C. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. J Pain 2004;5:413–19
   PubMed Web of Science ®Google Scholar
• Bernkop-SchnuK A, Scholler S, Biebel RG. Development of controlled drug release systems based on thiolated polymers. J Controlled Release 2000;66:39–48
   PubMed Web of Science ®Google Scholar
• Constantia EK, Andreas B. Thiolated polymers *thiomers: development and in vitro evaluation of chitosan–thioglycolic acid conjugates. Biomaterials 2001;22:2345–52
   PubMed Web of Science ®Google Scholar
• Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv Drug Delivery Rev 1998;34:221–33
   PubMed Web of Science ®Google Scholar
• Huang Y, Donovan MD. Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Delivery Rev 1998;29:147–55
   PubMed Web of Science ®Google Scholar
• Brooking J, Davis SS, Illum L. Transport of nanoparticles across the rat nasal mucosa. J Drug Target 2001;9:267–79
   PubMed Web of Science ®Google Scholar
• Fernández-Urrusuno R, Calvo P, et al. Enhancement of nasal absorption of insulin using chitosan nanoparticles. J Pharm Sci 1999;16:1576–81
   Google Scholar
• Vandenberg GW, Drolet C, Scott SL, Noüe JD. Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation. J Control Release 2001;77:297–307
   PubMed Web of Science ®Google Scholar
• Dong-Won L, Shawna AS, Richard FL, Shyam SM. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res 2006;7:1–10
   PubMedGoogle Scholar
• Worawan B, Hans EJ, Neti W, et al. Preparation and characterization of particles from chitosan with different molecular weights and their trimethyl chitosan derivatives for nasal immunization. J Met Mater Miner 2008;18:59–65
   Google Scholar
• Sadeghi AMM, Dorkoosh FA, Avadi MR, et al. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods. Int J Pharm 2008;355:299–306
   PubMed Web of Science ®Google Scholar
• Iqbal J, Sakloetsakun D, Bernkop-Schnürch A. Thiomers: inhibition of cytochrome P450 activity. Eur J Pharm Biopharm 2011;78:361–5
   PubMed Web of Science ®Google Scholar
• Illum L. Transport of drugs from the nasal cavity to central nervous system. Eur J Pharm Sci 2000;11:1–18
   PubMed Web of Science ®Google Scholar
• Thorne RG, Pronk GJ, Padmanabhan V, Frey WH. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004;127:481–96
   PubMed Web of Science ®Google Scholar
• Kitto KF, Haley JE, Wilcox GL. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 1992;148:1–5
   PubMed Web of Science ®Google Scholar
• Tao YX, Johns RA. Activation of cGMP-dependent protein kinase I alpha is required for N-methyl-d-aspartate- or nitric oxide-produced spinal thermal hyperalgesia. Eur J Pharmacol 2000;392:141–5
   PubMed Web of Science ®Google Scholar